BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 4139 hits with Last Name = 'johnson' and Initial = 't'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Aurora kinase A


(Homo sapiens (Human))
BDBM13534
PNG
(CHEMBL572878 | N-[4-({4-[(3-methyl-1H-pyrazol-5-yl...)
Show SMILES CN1CCN(CC1)c1cc(Nc2cc(C)n[nH]2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1
Show InChI InChI=1S/C23H28N8OS/c1-15-13-20(29-28-15)25-19-14-21(31-11-9-30(2)10-12-31)27-23(26-19)33-18-7-5-17(6-8-18)24-22(32)16-3-4-16/h5-8,13-14,16H,3-4,9-12H2,1-2H3,(H,24,32)(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
Purchase

CHEMBL
MMDB
PC cid
PC sid
PDB
UniChem

Patents


Similars

PDB
Article
PubMed
0.000600n/an/an/an/an/an/an/an/a



Centre de Recherches

Curated by ChEMBL


Assay Description
In vitro inhibition constant for Aurora-A


J Med Chem 49: 955-70 (2006)


Article DOI: 10.1021/jm050786h
BindingDB Entry DOI: 10.7270/Q24J0FXV
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Serine/threonine-protein kinase Aurora-C


(Homo sapiens (Human))
BDBM13534
PNG
(CHEMBL572878 | N-[4-({4-[(3-methyl-1H-pyrazol-5-yl...)
Show SMILES CN1CCN(CC1)c1cc(Nc2cc(C)n[nH]2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1
Show InChI InChI=1S/C23H28N8OS/c1-15-13-20(29-28-15)25-19-14-21(31-11-9-30(2)10-12-31)27-23(26-19)33-18-7-5-17(6-8-18)24-22(32)16-3-4-16/h5-8,13-14,16H,3-4,9-12H2,1-2H3,(H,24,32)(H2,25,26,27,28,29)
PDB

NCI pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
Purchase

CHEMBL
MMDB
PC cid
PC sid
PDB
UniChem

Patents


Similars

Article
PubMed
0.00460n/an/an/an/an/an/an/an/a



Centre de Recherches

Curated by ChEMBL


Assay Description
In vitro inhibition constant for Aurora-C


J Med Chem 49: 955-70 (2006)


Article DOI: 10.1021/jm050786h
BindingDB Entry DOI: 10.7270/Q24J0FXV
More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299749
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES Cn1cnc(c1)-c1cnc(N)c(OCC2CCN(CC2)c2nc(OCC3(CC3)C#N)nc(n2)C(=O)NC23CC(C2)C3)c1
Show InChI InChI=1S/C29H34N10O3/c1-38-13-21(33-17-38)20-8-22(23(31)32-12-20)41-14-18-2-6-39(7-3-18)26-34-24(25(40)37-29-9-19(10-29)11-29)35-27(36-26)42-16-28(15-30)4-5-28/h8,12-13,17-19H,2-7,9-11,14,16H2,1H3,(H2,31,32)(H,37,40)
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0100n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299975
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES Cn1cnc(c1)-c1cnc(N)c(OCC2CCN(CC2)c2nc(OCC3(CC3)C#N)nc(n2)C(=O)NC2(C)CCC2)c1
Show InChI InChI=1S/C29H36N10O3/c1-28(6-3-7-28)37-25(40)24-34-26(36-27(35-24)42-17-29(16-30)8-9-29)39-10-4-19(5-11-39)15-41-22-12-20(13-32-23(22)31)21-14-38(2)18-33-21/h12-14,18-19H,3-11,15,17H2,1-2H3,(H2,31,32)(H,37,40)
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0120n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299902
PNG
(6-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES C[C@H](CO)NC(=O)c1nc(OC[C@H]2CCCO2)nc(n1)N1CCC(COc2cc(cnc2N)-c2cn(C)cn2)CC1
Show InChI InChI=1S/C27H37N9O5/c1-17(13-37)31-25(38)24-32-26(34-27(33-24)41-15-20-4-3-9-39-20)36-7-5-18(6-8-36)14-40-22-10-19(11-29-23(22)28)21-12-35(2)16-30-21/h10-12,16-18,20,37H,3-9,13-15H2,1-2H3,(H2,28,29)(H,31,38)/t17-,20-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0120n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300079
PNG
(N-[(2R)-1- hydroxypropan-2- yl]-6-[4-(4- methoxy-1...)
Show SMILES COc1ccnc2[nH]cc(C3CCN(CC3)c3cc(nc(OC[C@H]4CCCO4)n3)C(=O)N[C@H](C)CO)c12
Show InChI InChI=1S/C26H34N6O5/c1-16(14-33)29-25(34)20-12-22(31-26(30-20)37-15-18-4-3-11-36-18)32-9-6-17(7-10-32)19-13-28-24-23(19)21(35-2)5-8-27-24/h5,8,12-13,16-18,33H,3-4,6-7,9-11,14-15H2,1-2H3,(H,27,28)(H,29,34)/t16-,18-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
<0.0130n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300011
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES C[C@H](NC(=O)c1nc(OCC2CC2)nc(n1)N1CCC(COc2cc(cnc2N)-c2cn(C)cn2)CC1)C(F)(F)F
Show InChI InChI=1S/C26H32F3N9O3/c1-15(26(27,28)29)33-23(39)22-34-24(36-25(35-22)41-13-16-3-4-16)38-7-5-17(6-8-38)12-40-20-9-18(10-31-21(20)30)19-11-37(2)14-32-19/h9-11,14-17H,3-8,12-13H2,1-2H3,(H2,30,31)(H,33,39)/t15-/m0/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
<0.0130n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300035
PNG
(2-(benzyloxy)-N- [(2R)-1- hydroxypropan-2- yl]-6-[...)
Show SMILES COc1ccnc2[nH]nc(C3CCN(CC3)c3cc(nc(OCc4ccccc4)n3)C(=O)N[C@H](C)CO)c12
Show InChI InChI=1S/C27H31N7O4/c1-17(15-35)29-26(36)20-14-22(31-27(30-20)38-16-18-6-4-3-5-7-18)34-12-9-19(10-13-34)24-23-21(37-2)8-11-28-25(23)33-32-24/h3-8,11,14,17,19,35H,9-10,12-13,15-16H2,1-2H3,(H,29,36)(H,28,32,33)/t17-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
<0.0130n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300077
PNG
(N-(3-amino-3- methylbutan- 2-yl)-2- (cyclo- propyl...)
Show SMILES COc1ccnc2[nH]cc(C3CCN(CC3)c3cc(nc(OCC4CC4)n3)C(=O)NC(C)C(C)(C)N)c12
Show InChI InChI=1S/C27H37N7O3/c1-16(27(2,3)28)31-25(35)20-13-22(33-26(32-20)37-15-17-5-6-17)34-11-8-18(9-12-34)19-14-30-24-23(19)21(36-4)7-10-29-24/h7,10,13-14,16-18H,5-6,8-9,11-12,15,28H2,1-4H3,(H,29,30)(H,31,35)
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
<0.0130n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300088
PNG
(N-[(2R)-1- hydroxypropan-2- yl]-2-[(2R)-2- methoxy...)
Show SMILES CO[C@H](C)COc1nc(cc(n1)C(=O)N[C@H](C)CO)N1CCC(CC1)c1c[nH]c2nccc(OC)c12
Show InChI InChI=1S/C25H34N6O5/c1-15(13-32)28-24(33)19-11-21(30-25(29-19)36-14-16(2)34-3)31-9-6-17(7-10-31)18-12-27-23-22(18)20(35-4)5-8-26-23/h5,8,11-12,15-17,32H,6-7,9-10,13-14H2,1-4H3,(H,26,27)(H,28,33)/t15-,16-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0140n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299998
PNG
(N-[(2R)-1- hydroxypropan-2- yl]-6-[4-(4- methoxy-1...)
Show SMILES COc1ccnc2[nH]nc(C3CCN(CC3)c3cc(nc(OC[C@H]4CCCO4)n3)C(=O)N[C@H](C)CO)c12
Show InChI InChI=1S/C25H33N7O5/c1-15(13-33)27-24(34)18-12-20(29-25(28-18)37-14-17-4-3-11-36-17)32-9-6-16(7-10-32)22-21-19(35-2)5-8-26-23(21)31-30-22/h5,8,12,15-17,33H,3-4,6-7,9-11,13-14H2,1-2H3,(H,27,34)(H,26,30,31)/t15-,17-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0150n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299931
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES CC(C)NC(=O)c1nc(OC[C@H]2CC2(F)F)nc(n1)N1CCC(COc2cc(cnc2N)-c2cn(C)cn2)CC1
Show InChI InChI=1S/C26H33F2N9O3/c1-15(2)32-23(38)22-33-24(35-25(34-22)40-13-18-9-26(18,27)28)37-6-4-16(5-7-37)12-39-20-8-17(10-30-21(20)29)19-11-36(3)14-31-19/h8,10-11,14-16,18H,4-7,9,12-13H2,1-3H3,(H2,29,30)(H,32,38)/t18-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0150n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299744
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES Cn1cnc(c1)-c1cnc(N)c(OCC2CCN(CC2)c2nc(OCC3(CC3)C#N)nc(n2)C(=O)NC2CCC2)c1
Show InChI InChI=1S/C28H34N10O3/c1-37-13-21(32-17-37)19-11-22(23(30)31-12-19)40-14-18-5-9-38(10-6-18)26-34-24(25(39)33-20-3-2-4-20)35-27(36-26)41-16-28(15-29)7-8-28/h11-13,17-18,20H,2-10,14,16H2,1H3,(H2,30,31)(H,33,39)
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0160n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299909
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES C[C@H](NC(=O)c1nc(OC[C@H]2CCCO2)nc(n1)N1CCC(COc2cc(cnc2N)-c2cn(C)cn2)CC1)C(F)(F)F
Show InChI InChI=1S/C27H34F3N9O4/c1-16(27(28,29)30)34-24(40)23-35-25(37-26(36-23)43-14-19-4-3-9-41-19)39-7-5-17(6-8-39)13-42-21-10-18(11-32-22(21)31)20-12-38(2)15-33-20/h10-12,15-17,19H,3-9,13-14H2,1-2H3,(H2,31,32)(H,34,40)/t16-,19+/m0/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0160n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300012
PNG
(N-(2- methoxyethyl)-6- [4-(4-methoxy-1H- pyrrolo[2...)
Show SMILES COCCNC(=O)c1cc(nc(OC[C@H]2CCCO2)n1)N1CCC(CC1)c1c[nH]c2nccc(OC)c12
Show InChI InChI=1S/C26H34N6O5/c1-34-13-9-28-25(33)20-14-22(31-26(30-20)37-16-18-4-3-12-36-18)32-10-6-17(7-11-32)19-15-29-24-23(19)21(35-2)5-8-27-24/h5,8,14-15,17-18H,3-4,6-7,9-13,16H2,1-2H3,(H,27,29)(H,28,33)/t18-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0160n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300049
PNG
((3,3- difluoroazetidin-1- yl)(2-{[(2R)-1- methoxyp...)
Show SMILES COC[C@@H](C)Oc1nc(cc(n1)C(=O)N1CC(F)(F)C1)N1CCC(CC1)c1c[nH]c2nccc(OC)c12
Show InChI InChI=1S/C25H30F2N6O4/c1-15(12-35-2)37-24-30-18(23(34)33-13-25(26,27)14-33)10-20(31-24)32-8-5-16(6-9-32)17-11-29-22-21(17)19(36-3)4-7-28-22/h4,7,10-11,15-16H,5-6,8-9,12-14H2,1-3H3,(H,28,29)/t15-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0180n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Aurora kinase B


(Homo sapiens (Human))
BDBM13534
PNG
(CHEMBL572878 | N-[4-({4-[(3-methyl-1H-pyrazol-5-yl...)
Show SMILES CN1CCN(CC1)c1cc(Nc2cc(C)n[nH]2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1
Show InChI InChI=1S/C23H28N8OS/c1-15-13-20(29-28-15)25-19-14-21(31-11-9-30(2)10-12-31)27-23(26-19)33-18-7-5-17(6-8-18)24-22(32)16-3-4-16/h5-8,13-14,16H,3-4,9-12H2,1-2H3,(H,24,32)(H2,25,26,27,28,29)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
Purchase

CHEMBL
MMDB
PC cid
PC sid
PDB
UniChem

Patents


Similars

PDB
Article
PubMed
0.0180n/an/an/an/an/an/an/an/a



Centre de Recherches

Curated by ChEMBL


Assay Description
In vitro inhibition constant for Aurora-B


J Med Chem 49: 955-70 (2006)


Article DOI: 10.1021/jm050786h
BindingDB Entry DOI: 10.7270/Q24J0FXV
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300007
PNG
(2-[(1- cyanocyclopropyl) methoxy]-N-[(2R)- 1-hydro...)
Show SMILES COc1ccnc2[nH]cc(C3CCN(CC3)c3cc(nc(OCC4(CC4)C#N)n3)C(=O)N[C@H](C)CO)c12
Show InChI InChI=1S/C26H31N7O4/c1-16(13-34)30-24(35)19-11-21(32-25(31-19)37-15-26(14-27)6-7-26)33-9-4-17(5-10-33)18-12-29-23-22(18)20(36-2)3-8-28-23/h3,8,11-12,16-17,34H,4-7,9-10,13,15H2,1-2H3,(H,28,29)(H,30,35)/t16-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
<0.0180n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299893
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES C[C@@H](NC(=O)c1nc(OCC2(CC2)C#N)nc(n1)N1CCC(COc2cc(cnc2N)-c2cn(C)cn2)CC1)C1CC1
Show InChI InChI=1S/C29H36N10O3/c1-18(20-3-4-20)34-26(40)25-35-27(37-28(36-25)42-16-29(15-30)7-8-29)39-9-5-19(6-10-39)14-41-23-11-21(12-32-24(23)31)22-13-38(2)17-33-22/h11-13,17-20H,3-10,14,16H2,1-2H3,(H2,31,32)(H,34,40)/t18-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0190n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300070
PNG
(N-[(2R)-3- hydroxy-3- methylbutan-2-yl]- 4-[4-(4-m...)
Show SMILES COc1ccnc2[nH]cc(C3CCN(CC3)c3nc(OC[C@H]4CCCO4)nc(n3)C(=O)N[C@H](C)C(C)(C)O)c12
Show InChI InChI=1S/C27H37N7O5/c1-16(27(2,3)36)30-24(35)23-31-25(33-26(32-23)39-15-18-6-5-13-38-18)34-11-8-17(9-12-34)19-14-29-22-21(19)20(37-4)7-10-28-22/h7,10,14,16-18,36H,5-6,8-9,11-13,15H2,1-4H3,(H,28,29)(H,30,35)/t16-,18-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0200n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
ALK tyrosine kinase receptor


(Homo sapiens (Human))
BDBM50018836
PNG
(CHEMBL3286826)
Show SMILES COc1nn(C)c2CN(C)C(=O)c3ccc(F)cc3[C@@H](C)Oc3nc(cnc3N)-c12
Show InChI InChI=1S/C20H21FN6O3/c1-10-13-7-11(21)5-6-12(13)20(28)26(2)9-15-16(18(29-4)25-27(15)3)14-8-23-17(22)19(24-14)30-10/h5-8,10H,9H2,1-4H3,(H2,22,23)/t10-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
<0.0200n/an/an/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-...


J Med Chem 57: 4720-44 (2014)


Article DOI: 10.1021/jm500261q
BindingDB Entry DOI: 10.7270/Q2K35W68
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase ROS


(Homo sapiens (Human))
BDBM50018830
PNG
(CHEMBL3286830)
Show SMILES C[C@H]1Oc2cc(cnc2N)-c2c(CN(C)C(=O)c3ccc(F)cc13)nn(C)c2C#N
Show InChI InChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
Purchase

CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
<0.0200n/an/an/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of ROS1 (unknown origin) by off-chip mobility shift assay


J Med Chem 57: 4720-44 (2014)


Article DOI: 10.1021/jm500261q
BindingDB Entry DOI: 10.7270/Q2K35W68
More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299917
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES Cn1cnc(c1)-c1cnc(N)c(OCC2CCN(CC2)c2nc(OCC3(CC3)C#N)nc(n2)C(=O)NC(C)(C)C)c1
Show InChI InChI=1S/C28H36N10O3/c1-27(2,3)36-24(39)23-33-25(35-26(34-23)41-16-28(15-29)7-8-28)38-9-5-18(6-10-38)14-40-21-11-19(12-31-22(21)30)20-13-37(4)17-32-20/h11-13,17-18H,5-10,14,16H2,1-4H3,(H2,30,31)(H,36,39)
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0200n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase ROS


(Homo sapiens (Human))
BDBM50448785
PNG
(CHEMBL3128069)
Show SMILES C[C@@H](Oc1cc(cnc1N)-c1sc(nc1C)[C@](C)(O)CO)c1cc(F)ccc1-n1nccn1
Show InChI InChI=1S/C22H23FN6O3S/c1-12-19(33-21(28-12)22(3,31)11-30)14-8-18(20(24)25-10-14)32-13(2)16-9-15(23)4-5-17(16)29-26-6-7-27-29/h4-10,13,30-31H,11H2,1-3H3,(H2,24,25)/t13-,22-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
Purchase

CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
0.0200n/an/an/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of ROS1 (unknown origin) by Pfizer mobility shift assay


J Med Chem 57: 1170-87 (2014)


Article DOI: 10.1021/jm401805h
BindingDB Entry DOI: 10.7270/Q29C6ZX5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300090
PNG
(N-[(2R)-1- hydroxypropan-2- yl]-2-[(2S)-2- methoxy...)
Show SMILES CO[C@@H](C)COc1nc(cc(n1)C(=O)N[C@H](C)CO)N1CCC(CC1)c1c[nH]c2nccc(OC)c12
Show InChI InChI=1S/C25H34N6O5/c1-15(13-32)28-24(33)19-11-21(30-25(29-19)36-14-16(2)34-3)31-9-6-17(7-10-31)18-12-27-23-22(18)20(35-4)5-8-26-23/h5,8,11-12,15-17,32H,6-7,9-10,13-14H2,1-4H3,(H,26,27)(H,28,33)/t15-,16+/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0200n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299901
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES Cn1cnc(c1)-c1cnc(N)c(OCC2CCN(CC2)c2nc(OC[C@H]3C[C@H]3C#N)nc(n2)C(=O)NC(C)(C)C)c1
Show InChI InChI=1S/C28H36N10O3/c1-28(2,3)36-25(39)24-33-26(35-27(34-24)41-15-20-9-18(20)11-29)38-7-5-17(6-8-38)14-40-22-10-19(12-31-23(22)30)21-13-37(4)16-32-21/h10,12-13,16-18,20H,5-9,14-15H2,1-4H3,(H2,30,31)(H,36,39)/t18-,20+/m0/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0210n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299996
PNG
(4-[(1- cyanocyclopropyl) methoxy]-6-[4-(4- methoxy...)
Show SMILES COc1ccnc2[nH]cc(C3CCN(CC3)c3nc(OCC4(CC4)C#N)nc(n3)C(=O)N[C@@H](C)C(F)(F)F)c12
Show InChI InChI=1S/C25H27F3N8O3/c1-14(25(26,27)28)32-21(37)20-33-22(35-23(34-20)39-13-24(12-29)6-7-24)36-9-4-15(5-10-36)16-11-31-19-18(16)17(38-2)3-8-30-19/h3,8,11,14-15H,4-7,9-10,13H2,1-2H3,(H,30,31)(H,32,37)/t14-/m0/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0210n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300125
PNG
(N-cyclobutyl-4- {[(2R)-1- methoxypropan-2- yl]oxy}...)
Show SMILES COC[C@@H](C)Oc1nc(nc(n1)C(=O)NC1CCC1)N1CCC(CC1)c1n[nH]c2nccc(OC)c12
Show InChI InChI=1S/C24H32N8O4/c1-14(13-34-2)36-24-28-21(22(33)26-16-5-4-6-16)27-23(29-24)32-11-8-15(9-12-32)19-18-17(35-3)7-10-25-20(18)31-30-19/h7,10,14-16H,4-6,8-9,11-13H2,1-3H3,(H,26,33)(H,25,30,31)/t14-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0210n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300104
PNG
(4-(benzyloxy)-N- [(2R)-1- hydroxypropan-2- yl]-6-[...)
Show SMILES COc1ccnc2[nH]cc(C3CCN(CC3)c3nc(OCc4ccccc4)nc(n3)C(=O)N[C@H](C)CO)c12
Show InChI InChI=1S/C27H31N7O4/c1-17(15-35)30-25(36)24-31-26(33-27(32-24)38-16-18-6-4-3-5-7-18)34-12-9-19(10-13-34)20-14-29-23-22(20)21(37-2)8-11-28-23/h3-8,11,14,17,19,35H,9-10,12-13,15-16H2,1-2H3,(H,28,29)(H,30,36)/t17-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0250n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299891
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES CC[C@@H](C)NC(=O)c1nc(OCC2(CC2)C#N)nc(n1)N1CCC(COc2cc(cnc2N)-c2cn(C)cn2)CC1
Show InChI InChI=1S/C28H36N10O3/c1-4-18(2)33-25(39)24-34-26(36-27(35-24)41-16-28(15-29)7-8-28)38-9-5-19(6-10-38)14-40-22-11-20(12-31-23(22)30)21-13-37(3)17-32-21/h11-13,17-19H,4-10,14,16H2,1-3H3,(H2,30,31)(H,33,39)/t18-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0260n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300064
PNG
(N-[(2R)-1- hydroxypropan-2- yl]-4-{[(2R)-1- methox...)
Show SMILES COC[C@@H](C)Oc1nc(nc(n1)C(=O)N[C@H](C)CO)N1CCC(CC1)c1c[nH]c2nccc(OC)c12
Show InChI InChI=1S/C24H33N7O5/c1-14(12-32)27-22(33)21-28-23(30-24(29-21)36-15(2)13-34-3)31-9-6-16(7-10-31)17-11-26-20-19(17)18(35-4)5-8-25-20/h5,8,11,14-16,32H,6-7,9-10,12-13H2,1-4H3,(H,25,26)(H,27,33)/t14-,15-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0280n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299746
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES Cn1cnc(c1)-c1cnc(N)c(OCC2CCN(CC2)c2nc(OC[C@H]3C[C@H]3C#N)nc(n2)C(=O)NC23CC(C2)C3)c1
Show InChI InChI=1S/C29H34N10O3/c1-38-13-22(33-16-38)20-7-23(24(31)32-12-20)41-14-17-2-4-39(5-3-17)27-34-25(26(40)37-29-8-18(9-29)10-29)35-28(36-27)42-15-21-6-19(21)11-30/h7,12-13,16-19,21H,2-6,8-10,14-15H2,1H3,(H2,31,32)(H,37,40)/t18?,19-,21+,29?/m0/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0280n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299890
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES Cn1cnc(c1)-c1cnc(N)c(OCC2CCN(CC2)c2nc(OCC3(CC3)C#N)nc(n2)C(=O)NCC(C)(C)C)c1
Show InChI InChI=1S/C29H38N10O3/c1-28(2,3)16-33-25(40)24-35-26(37-27(36-24)42-17-29(15-30)7-8-29)39-9-5-19(6-10-39)14-41-22-11-20(12-32-23(22)31)21-13-38(4)18-34-21/h11-13,18-19H,5-10,14,16-17H2,1-4H3,(H2,31,32)(H,33,40)
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0280n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299930
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES C[C@H](CO)NC(=O)c1nc(OC[C@H]2CC2(F)F)nc(n1)N1CCC(COc2cc(cnc2N)-c2cn(C)cn2)CC1
Show InChI InChI=1S/C26H33F2N9O4/c1-15(11-38)32-23(39)22-33-24(35-25(34-22)41-13-18-8-26(18,27)28)37-5-3-16(4-6-37)12-40-20-7-17(9-30-21(20)29)19-10-36(2)14-31-19/h7,9-10,14-16,18,38H,3-6,8,11-13H2,1-2H3,(H2,29,30)(H,32,39)/t15-,18-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0290n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299803
PNG
(N- (bicyclo[1.1.1]pent- 1-yl)-4-{[(1S,2R)- 2- cyan...)
Show SMILES COc1ccnc2[nH]nc(C3CCN(CC3)c3nc(OC[C@H]4C[C@H]4C#N)nc(n3)C(=O)NC34CC(C3)C4)c12
Show InChI InChI=1S/C26H29N9O3/c1-37-18-2-5-28-21-19(18)20(33-34-21)15-3-6-35(7-4-15)24-29-22(23(36)32-26-9-14(10-26)11-26)30-25(31-24)38-13-17-8-16(17)12-27/h2,5,14-17H,3-4,6-11,13H2,1H3,(H,32,36)(H,28,33,34)/t14?,16-,17+,26?/m0/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0300n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor FLT3


(Homo sapiens (Human))
BDBM13534
PNG
(CHEMBL572878 | N-[4-({4-[(3-methyl-1H-pyrazol-5-yl...)
Show SMILES CN1CCN(CC1)c1cc(Nc2cc(C)n[nH]2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1
Show InChI InChI=1S/C23H28N8OS/c1-15-13-20(29-28-15)25-19-14-21(31-11-9-30(2)10-12-31)27-23(26-19)33-18-7-5-17(6-8-18)24-22(32)16-3-4-16/h5-8,13-14,16H,3-4,9-12H2,1-2H3,(H,24,32)(H2,25,26,27,28,29)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
Purchase

CHEMBL
MMDB
PC cid
PC sid
PDB
UniChem

Patents


Similars

Article
PubMed
0.0300n/an/an/an/an/an/an/an/a



Centre de Recherches

Curated by ChEMBL


Assay Description
In vitro inhibition constant for FLT-3


J Med Chem 49: 955-70 (2006)


Article DOI: 10.1021/jm050786h
BindingDB Entry DOI: 10.7270/Q24J0FXV
More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300103
PNG
(4-[(1- cyanocyclopropyl) methoxy]-N-[(2R)- 1-hydro...)
Show SMILES COc1ccnc2[nH]cc(C3CCN(CC3)c3nc(OCC4(CC4)C#N)nc(n3)C(=O)N[C@H](C)CO)c12
Show InChI InChI=1S/C25H30N8O4/c1-15(12-34)29-22(35)21-30-23(32-24(31-21)37-14-25(13-26)6-7-25)33-9-4-16(5-10-33)17-11-28-20-19(17)18(36-2)3-8-27-20/h3,8,11,15-16,34H,4-7,9-10,12,14H2,1-2H3,(H,27,28)(H,29,35)/t15-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0300n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300071
PNG
(N-[(2R)-1- hydroxypropan-2- yl]-4-[4-(4- methoxy-1...)
Show SMILES COc1ccnc2[nH]cc(C3CCN(CC3)c3nc(OC[C@H]4CCCO4)nc(n3)C(=O)N[C@H](C)CO)c12
Show InChI InChI=1S/C25H33N7O5/c1-15(13-33)28-23(34)22-29-24(31-25(30-22)37-14-17-4-3-11-36-17)32-9-6-16(7-10-32)18-12-27-21-20(18)19(35-2)5-8-26-21/h5,8,12,15-17,33H,3-4,6-7,9-11,13-14H2,1-2H3,(H,26,27)(H,28,34)/t15-,17-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0300n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300099
PNG
(4-{[(1S,2R)-2- cyanocyclopropyl] methoxy}-N-[(2R)-...)
Show SMILES COc1ccnc2[nH]cc(C3CCN(CC3)c3nc(OC[C@H]4C[C@H]4C#N)nc(n3)C(=O)N[C@H](C)C(C)(C)O)c12
Show InChI InChI=1S/C27H34N8O4/c1-15(27(2,3)37)31-24(36)23-32-25(34-26(33-23)39-14-18-11-17(18)12-28)35-9-6-16(7-10-35)19-13-30-22-21(19)20(38-4)5-8-29-22/h5,8,13,15-18,37H,6-7,9-11,14H2,1-4H3,(H,29,30)(H,31,36)/t15-,17+,18-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0320n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299852
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES Cn1cnc(c1)-c1cnc(N)c(OCC2CCN(CC2)c2nc(OCC3(CC3)C#N)nc(n2)C(=O)NCC2CC2)c1
Show InChI InChI=1S/C28H34N10O3/c1-37-13-21(33-17-37)20-10-22(23(30)31-12-20)40-14-19-4-8-38(9-5-19)26-34-24(25(39)32-11-18-2-3-18)35-27(36-26)41-16-28(15-29)6-7-28/h10,12-13,17-19H,2-9,11,14,16H2,1H3,(H2,30,31)(H,32,39)
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0320n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299922
PNG
(6-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES C[C@H](CO)NC(=O)c1cc(nc(OC[C@@H]2CC2(F)F)n1)N1CCC(COc2cc(cnc2N)-c2cn(C)cn2)CC1
Show InChI InChI=1S/C27H34F2N8O4/c1-16(12-38)33-25(39)20-8-23(35-26(34-20)41-14-19-9-27(19,28)29)37-5-3-17(4-6-37)13-40-22-7-18(10-31-24(22)30)21-11-36(2)15-32-21/h7-8,10-11,15-17,19,38H,3-6,9,12-14H2,1-2H3,(H2,30,31)(H,33,39)/t16-,19+/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0330n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300056
PNG
(N-(3-amino-3- methylbutan-2-yl)- 2-{[(2R)-1- metho...)
Show SMILES COC[C@@H](C)Oc1nc(cc(n1)C(=O)NC(C)C(C)(C)N)N1CCC(CC1)c1c[nH]c2nccc(OC)c12
Show InChI InChI=1S/C27H39N7O4/c1-16(15-36-5)38-26-32-20(25(35)31-17(2)27(3,4)28)13-22(33-26)34-11-8-18(9-12-34)19-14-30-24-23(19)21(37-6)7-10-29-24/h7,10,13-14,16-18H,8-9,11-12,15,28H2,1-6H3,(H,29,30)(H,31,35)/t16-,17?/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0340n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300087
PNG
(N-[(1R,2R)-2- hydroxy- cyclobutyl]- 6-[4-(4-methox...)
Show SMILES COc1ccnc2[nH]nc(C3CCN(CC3)c3cc(nc(OC[C@H]4CCCO4)n3)C(=O)N[C@@H]3CC[C@H]3O)c12
Show InChI InChI=1S/C26H33N7O5/c1-36-20-6-9-27-24-22(20)23(31-32-24)15-7-10-33(11-8-15)21-13-18(25(35)28-17-4-5-19(17)34)29-26(30-21)38-14-16-3-2-12-37-16/h6,9,13,15-17,19,34H,2-5,7-8,10-12,14H2,1H3,(H,28,35)(H,27,31,32)/t16-,17-,19-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0340n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299911
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES C[C@@H](NC(=O)c1nc(OC[C@H]2CCCO2)nc(n1)N1CCC(COc2cc(cnc2N)-c2cn(C)cn2)CC1)C(C)(C)O
Show InChI InChI=1S/C29H41N9O5/c1-18(29(2,3)40)33-26(39)25-34-27(36-28(35-25)43-16-21-6-5-11-41-21)38-9-7-19(8-10-38)15-42-23-12-20(13-31-24(23)30)22-14-37(4)17-32-22/h12-14,17-19,21,40H,5-11,15-16H2,1-4H3,(H2,30,31)(H,33,39)/t18-,21-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0340n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300098
PNG
(4-{[(1S,2R)-2- cyanocyclopropyl] methoxy}-N-[(2R)-...)
Show SMILES COc1ccnc2[nH]cc(C3CCN(CC3)c3nc(OC[C@H]4C[C@H]4C#N)nc(n3)C(=O)N[C@H](C)CO)c12
Show InChI InChI=1S/C25H30N8O4/c1-14(12-34)29-23(35)22-30-24(32-25(31-22)37-13-17-9-16(17)10-26)33-7-4-15(5-8-33)18-11-28-21-20(18)19(36-2)3-6-27-21/h3,6,11,14-17,34H,4-5,7-9,12-13H2,1-2H3,(H,27,28)(H,29,35)/t14-,16+,17-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0350n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300101
PNG
(4-(benzyloxy)-N- [(2R)-1- hydroxypropan-2- yl]-6-[...)
Show SMILES COc1ccnc2[nH]nc(C3CCN(CC3)c3nc(OCc4ccccc4)nc(n3)C(=O)N[C@H](C)CO)c12
Show InChI InChI=1S/C26H30N8O4/c1-16(14-35)28-24(36)23-29-25(31-26(30-23)38-15-17-6-4-3-5-7-17)34-12-9-18(10-13-34)21-20-19(37-2)8-11-27-22(20)33-32-21/h3-8,11,16,18,35H,9-10,12-15H2,1-2H3,(H,28,36)(H,27,32,33)/t16-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0370n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300063
PNG
(N-[(2R)-3- hydroxy-3- methylbutan-2-yl]- 4-{[(2R)-...)
Show SMILES COC[C@@H](C)Oc1nc(nc(n1)C(=O)N[C@H](C)C(C)(C)O)N1CCC(CC1)c1c[nH]c2nccc(OC)c12
Show InChI InChI=1S/C26H37N7O5/c1-15(14-36-5)38-25-31-22(23(34)29-16(2)26(3,4)35)30-24(32-25)33-11-8-17(9-12-33)18-13-28-21-20(18)19(37-6)7-10-27-21/h7,10,13,15-17,35H,8-9,11-12,14H2,1-6H3,(H,27,28)(H,29,34)/t15-,16-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0380n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300102
PNG
(4-[(1- cyanocyclopropyl) methoxy]-N-[(2R)- 3-hydro...)
Show SMILES COc1ccnc2[nH]cc(C3CCN(CC3)c3nc(OCC4(CC4)C#N)nc(n3)C(=O)N[C@H](C)C(C)(C)O)c12
Show InChI InChI=1S/C27H34N8O4/c1-16(26(2,3)37)31-23(36)22-32-24(34-25(33-22)39-15-27(14-28)8-9-27)35-11-6-17(7-12-35)18-13-30-21-20(18)19(38-4)5-10-29-21/h5,10,13,16-17,37H,6-9,11-12,15H2,1-4H3,(H,29,30)(H,31,36)/t16-/m1/s1
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0380n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM299849
PNG
(4-[4-({[2-amino-5- (1-methyl-1H- imidazol-4- yl)py...)
Show SMILES Cn1cnc(c1)-c1cnc(N)c(OCC2CCN(CC2)c2nc(OCC3(CC3)C#N)nc(n2)C(=O)NCC(F)(F)F)c1
Show InChI InChI=1S/C26H29F3N10O3/c1-38-10-18(34-15-38)17-8-19(20(31)32-9-17)41-11-16-2-6-39(7-3-16)23-35-21(22(40)33-13-26(27,28)29)36-24(37-23)42-14-25(12-30)4-5-25/h8-10,15-16H,2-7,11,13-14H2,1H3,(H2,31,32)(H,33,40)
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0390n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase receptor UFO


(Homo sapiens (Human))
BDBM300061
PNG
(N-(3-amino-3- methylbutan-2-yl)- 2-[(1- cyanocyclo...)
Show SMILES COc1ccnc2[nH]cc(C3CCN(CC3)c3cc(nc(OCC4(CC4)C#N)n3)C(=O)NC(C)C(C)(C)N)c12
Show InChI InChI=1S/C28H36N8O3/c1-17(27(2,3)30)33-25(37)20-13-22(35-26(34-20)39-16-28(15-29)8-9-28)36-11-6-18(7-12-36)19-14-32-24-23(19)21(38-4)5-10-31-24/h5,10,13-14,17-18H,6-9,11-12,16,30H2,1-4H3,(H,31,32)(H,33,37)
PDB

KEGG

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
0.0400n/an/an/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
AXL enzyme inhibition (% inhibition, Kiapp and Ki values) by small molecule inhibitors was evaluated using a fluorescence-based microfluidic mobility...


US Patent US9593097 (2017)

More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 4139 total )  |  Next  |  Last  >>
Jump to: